Clinical trials: Rhizarthrosis
Rhizarthrosis
Durolane SJ for Treatment of Rhizarthrosis
The main objective of the trial is to assess the clinical changes in terms of physical examination, VAS Scale and the Quick-DASH questionnaire, and the biomechanical parameters in terms of mobility of the TMC joint, the grip…
- Trial name
- NCT02676284
- Testing
- Durolane SJ
- Where
- 3 sites in Spain
- Volunteers
- 36 people
- Sponsor
- Zambon SAU
Trapeziometacarpal Osteoarthritis, Rhizarthrosis
Evaluation of the Performance and Safety of a Type I Collagen-Based Medical Device (MD-Small Joints Collagen Medical Device) i the Treatment of RHIZOARTROSIS
Collagen is a structural protein biopolymer consisting of three polypeptide chains wrapped around to form a right-handed triple helix.
- Conditions
- Trapeziometacarpal Osteoarthritis, Rhizarthrosis, MEDICAL DEVICE, Infiltrate
- Trial name
- SMAGENART (NCT06781554)
- Testing
- MD-Small Joints Collagen Medical Device
- Where
- Italy
- Volunteers
- 42 people
- Sponsor
- Guna S.p.a
Osteoarthritis of the Small Joints of the Hand
Clinical Validation Study of Personalized Orthopedic Splints With 3D Technology in Patients With Rhizarthrosis
Osteoarthritis of the hand is a chronic joint disease that usually affects one or more of the finger joints and it is a major cause of disability.
- Trial name
- NCT04678622
- Testing
- Bioferula3D
- Where
- 2 sites in Spain
- Volunteers
- 39 people, healthy volunteers welcome
- Sponsor
- Optimus3D S.L.
Rhizarthrosis
Routine Application of Ostenil® Mini in Patients with Rhizarthrosis
PMCF study to observe the routine application of Ostenil® Mini in the treatment of pain and restricted mobility in degenerative and traumatic changes of the CMC joint.
- Trial name
- NCT03879434
- Testing
- Ostenil® Mini
- Where
- 6 sites in Germany
- Volunteers
- 110 people
- Sponsor
- TRB Chemedica AG
Osteoarthritis Thumb
Influence of the Radiological Stage on the Efficiency of Viscosupplementation in Basal Thumb Arthritis
The rhizarthrose is the most frequent affection of the hand at the age fifty and beyond. For the moderate forms of the disease, the majority of the studies recommend the recourse to the viscosupplement because of its efficiency…
- Trial name
- INSTINCT (NCT03622736)
- Where
- France
- Volunteers
- 122 people
- Sponsor
- Labrha